最新更新 :
18/04/2024
其它   Filgrastim  
注射液
溶液稳定性 混合物稳定性 影响稳定性的因素 兼容性 用药途径 引用文献 PDF

商品名   商品名     

商品名仅供参考, 药品所用的辅料可能依国家或厂商不同有所不同。

Accofil 德国, 比利时, 英国
Biocilin 墨西哥
Duperan 智利
Filgen 阿根廷
Foltran 智利
Granulokine 希腊, 意大利
Hebervital 哥伦比亚
Inmunef 哥伦比亚
Leucosos 哥伦比亚
Lioplim 智利
Neupogen 丹麦, 克罗地亚, 南非, 土耳其, 奥地利, 斯洛文尼亚, 比利时, 法国, 波兰, 瑞典, 瑞士, 美国, 芬兰, 英国, 荷兰, 葡萄牙, 西班牙
Neutromax 阿根廷
Neutropine 阿根廷
Nivestim 德国, 挪威, 比利时, 法国, 英国, 荷兰
Ratiograstim 奥地利, 德国, 瑞典, 英国
Tevagrastim 德国, 挪威, 瑞典, 瑞士, 英国, 荷兰
引用文献   注射液   引用文献 : Filgrastim  
种类 出版物
99 文献 Trissel LA, Martinez JF.
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
104 文献 Hall PD, Yui D, Lyons S, Bosso JA.
Compatibility of filgrastim with selected antimicrobial drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 185-189.
182 文献 Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60.
244 文献 Trissel LA, Martinez JF.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1907-1913.
2269 文献 Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H.
Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
3128 实验室 Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit
Prostrakan 2013
3249 文献 Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB.
Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
3256 文献 Burnett B, Radic I.
Stability of Hospira filgrastim following changes to thermal and photic storage conditions.
EJHP 2011 ; 17, 5: 49-56.
3474 实验室 Fluorouracil - Summary of Product Characteristics
Accord Healthcare Limited 2009
3618 实验室 Filgrastim (Neupogen®) - Summary of Product Characteristics
Amgen 2014
3828 海报 Thabit A.K, Hamada Y, Nicolau D.P.
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
ASHP Midyear 2015
3829 海报 So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.
Compatibility of isavunazonium sulfate during simulated Y-site administration.
ASHP Midyear 2015
4055 文献 Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D.
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 , 75, 1:36-44
4380 实验室 Posaconazole (Noxafil®) - Summary of Product Characteristics
Merck Sharp & Dohme Limited 2019
4471 实验室 Amétycine 10 mg poudre pour solution injectable - Résumé des caractéristiques du produit - Oct 10, 2019
Kyowa Kirin Pharma 2019
4521 文献 Polo C, D’Huart E, Lesperlette G, Vigneron J, Meyer F, Demoré B.
Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit.
Pharmaceutical Technology in Hospital Pharmacy 2020
4650 实验室 Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021.
Advanz Pharma 2021

  Mentions Légales